Benefits of Early CAR T-Cell Therapy in Multiple Myeloma

Stephanie Gregory, MS, FNP-C, BMTCN, and Jacob Bartlett, PA-C, from Northside Hospital discuss the clinical advantages of utilizing CAR T-cell therapy in earlier lines of treatment for multiple myeloma. They emphasize that early intervention, facilitated by prompt referrals to specialized centers, can lead to more durable remissions and a better quality of life for patients by utilizing their T-cells before they become exhausted by multiple prior treatments.